The Head of Bayer in the US on pharma and a new $250M cell Tx facility in Berkeley, CA. #HLTH2023
- blonca9
- Oct 11, 2023
- 1 min read
Sebastian Guth discusses areas of focus for Bayer like oncology, cardiovascular disease, and women's health, and platforms such as radiopharmaceuticals and cell therapies. He also talks about investing in a new 100,000 square foot cell therapy manufacturing plant in Berkeley, CA.